Cargando…
Network Pharmacology Study of Bioactive Components and Molecular Mechanisms of the Glycoside Fraction from Picrorhiza scrophulariiflora Against Experimental Colitis
PURPOSE: To explore the potential mechanism of glycosidic fraction of Picrorhiza scrophulariiflora Pennell (GPS) extract for the treatment of colitis using UPLC-QTOF-MS analysis, network pharmacology and experimental research. METHODS: The active components of GPS extract were identified by UPLC-QTO...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224697/ https://www.ncbi.nlm.nih.gov/pubmed/37249930 http://dx.doi.org/10.2147/DDDT.S407339 |
_version_ | 1785050253644267520 |
---|---|
author | Wu, Peigen Chang, Churui Zhu, Guanglin Zhai, Lixiang Zhang, Xu Huan, Qiuchan Gao, Zhengxian Deng, Huan Liang, Yue Xiao, Haitao |
author_facet | Wu, Peigen Chang, Churui Zhu, Guanglin Zhai, Lixiang Zhang, Xu Huan, Qiuchan Gao, Zhengxian Deng, Huan Liang, Yue Xiao, Haitao |
author_sort | Wu, Peigen |
collection | PubMed |
description | PURPOSE: To explore the potential mechanism of glycosidic fraction of Picrorhiza scrophulariiflora Pennell (GPS) extract for the treatment of colitis using UPLC-QTOF-MS analysis, network pharmacology and experimental research. METHODS: The active components of GPS extract were identified by UPLC-QTOF-MS analysis and extracted their targets from the databases, which was used for network pharmacology analysis. Kyoto Encyclopedia of genes and genomes (KEGG) pathway analysis was performed to discover potential therapeutic mechanisms, and the network pharmacology results were then validated by in vivo and in vitro experiments. RESULTS: The results showed that GPS extract significantly alleviated the clinical signs of colitis, including body weight, disease activity index, colon shortening, and colon tissue damage, and inhibited the transcription and production of colonic IL-1β and IL-6 in DSS-induced colitis mice. In vitro, GPS extract also significantly suppressed nitric oxide (NO) production, iNOS expression, IL-1β and IL-6 transcription of LPS-activated RAW 264.7 cells. Network pharmacology integrated with experimental validation identified that GPS extract significantly suppressed Akt, p38, ERK, and JNK phosphorylation in vivo and in vitro, and luteolin, apocynin, caffeic acid, caffeic acid methyl ester, luteoloside, picroside II, aucubin, cinnamic acid, vanillic acid, and sweroside were the main components responsible for the anti-inflammatory effect of GPS. These findings demonstrate that the potential anti-inflammatory effect of GPS extract against colitis is achieved through suppressing PI3K/Akt and MAPK pathways, and that the abovementioned active components mainly exerted its anti-inflammatory effect. CONCLUSION: The therapeutic effect of GPS extract on colitis is related to PI3K/Akt and MAPK pathways, which is a promising remedy for colitis therapy. |
format | Online Article Text |
id | pubmed-10224697 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-102246972023-05-28 Network Pharmacology Study of Bioactive Components and Molecular Mechanisms of the Glycoside Fraction from Picrorhiza scrophulariiflora Against Experimental Colitis Wu, Peigen Chang, Churui Zhu, Guanglin Zhai, Lixiang Zhang, Xu Huan, Qiuchan Gao, Zhengxian Deng, Huan Liang, Yue Xiao, Haitao Drug Des Devel Ther Original Research PURPOSE: To explore the potential mechanism of glycosidic fraction of Picrorhiza scrophulariiflora Pennell (GPS) extract for the treatment of colitis using UPLC-QTOF-MS analysis, network pharmacology and experimental research. METHODS: The active components of GPS extract were identified by UPLC-QTOF-MS analysis and extracted their targets from the databases, which was used for network pharmacology analysis. Kyoto Encyclopedia of genes and genomes (KEGG) pathway analysis was performed to discover potential therapeutic mechanisms, and the network pharmacology results were then validated by in vivo and in vitro experiments. RESULTS: The results showed that GPS extract significantly alleviated the clinical signs of colitis, including body weight, disease activity index, colon shortening, and colon tissue damage, and inhibited the transcription and production of colonic IL-1β and IL-6 in DSS-induced colitis mice. In vitro, GPS extract also significantly suppressed nitric oxide (NO) production, iNOS expression, IL-1β and IL-6 transcription of LPS-activated RAW 264.7 cells. Network pharmacology integrated with experimental validation identified that GPS extract significantly suppressed Akt, p38, ERK, and JNK phosphorylation in vivo and in vitro, and luteolin, apocynin, caffeic acid, caffeic acid methyl ester, luteoloside, picroside II, aucubin, cinnamic acid, vanillic acid, and sweroside were the main components responsible for the anti-inflammatory effect of GPS. These findings demonstrate that the potential anti-inflammatory effect of GPS extract against colitis is achieved through suppressing PI3K/Akt and MAPK pathways, and that the abovementioned active components mainly exerted its anti-inflammatory effect. CONCLUSION: The therapeutic effect of GPS extract on colitis is related to PI3K/Akt and MAPK pathways, which is a promising remedy for colitis therapy. Dove 2023-05-23 /pmc/articles/PMC10224697/ /pubmed/37249930 http://dx.doi.org/10.2147/DDDT.S407339 Text en © 2023 Wu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Wu, Peigen Chang, Churui Zhu, Guanglin Zhai, Lixiang Zhang, Xu Huan, Qiuchan Gao, Zhengxian Deng, Huan Liang, Yue Xiao, Haitao Network Pharmacology Study of Bioactive Components and Molecular Mechanisms of the Glycoside Fraction from Picrorhiza scrophulariiflora Against Experimental Colitis |
title | Network Pharmacology Study of Bioactive Components and Molecular Mechanisms of the Glycoside Fraction from Picrorhiza scrophulariiflora Against Experimental Colitis |
title_full | Network Pharmacology Study of Bioactive Components and Molecular Mechanisms of the Glycoside Fraction from Picrorhiza scrophulariiflora Against Experimental Colitis |
title_fullStr | Network Pharmacology Study of Bioactive Components and Molecular Mechanisms of the Glycoside Fraction from Picrorhiza scrophulariiflora Against Experimental Colitis |
title_full_unstemmed | Network Pharmacology Study of Bioactive Components and Molecular Mechanisms of the Glycoside Fraction from Picrorhiza scrophulariiflora Against Experimental Colitis |
title_short | Network Pharmacology Study of Bioactive Components and Molecular Mechanisms of the Glycoside Fraction from Picrorhiza scrophulariiflora Against Experimental Colitis |
title_sort | network pharmacology study of bioactive components and molecular mechanisms of the glycoside fraction from picrorhiza scrophulariiflora against experimental colitis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224697/ https://www.ncbi.nlm.nih.gov/pubmed/37249930 http://dx.doi.org/10.2147/DDDT.S407339 |
work_keys_str_mv | AT wupeigen networkpharmacologystudyofbioactivecomponentsandmolecularmechanismsoftheglycosidefractionfrompicrorhizascrophulariifloraagainstexperimentalcolitis AT changchurui networkpharmacologystudyofbioactivecomponentsandmolecularmechanismsoftheglycosidefractionfrompicrorhizascrophulariifloraagainstexperimentalcolitis AT zhuguanglin networkpharmacologystudyofbioactivecomponentsandmolecularmechanismsoftheglycosidefractionfrompicrorhizascrophulariifloraagainstexperimentalcolitis AT zhailixiang networkpharmacologystudyofbioactivecomponentsandmolecularmechanismsoftheglycosidefractionfrompicrorhizascrophulariifloraagainstexperimentalcolitis AT zhangxu networkpharmacologystudyofbioactivecomponentsandmolecularmechanismsoftheglycosidefractionfrompicrorhizascrophulariifloraagainstexperimentalcolitis AT huanqiuchan networkpharmacologystudyofbioactivecomponentsandmolecularmechanismsoftheglycosidefractionfrompicrorhizascrophulariifloraagainstexperimentalcolitis AT gaozhengxian networkpharmacologystudyofbioactivecomponentsandmolecularmechanismsoftheglycosidefractionfrompicrorhizascrophulariifloraagainstexperimentalcolitis AT denghuan networkpharmacologystudyofbioactivecomponentsandmolecularmechanismsoftheglycosidefractionfrompicrorhizascrophulariifloraagainstexperimentalcolitis AT liangyue networkpharmacologystudyofbioactivecomponentsandmolecularmechanismsoftheglycosidefractionfrompicrorhizascrophulariifloraagainstexperimentalcolitis AT xiaohaitao networkpharmacologystudyofbioactivecomponentsandmolecularmechanismsoftheglycosidefractionfrompicrorhizascrophulariifloraagainstexperimentalcolitis |